Highlights in Non–Small Cell Lung Cancer From the IASLC 2023 World Conference on Lung Cancer

A Review of Selected Presentations From the IASLC 2023 WCLC September 9-12, 2023  •  Singapore Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non–Small Cell Lung Cancer: […]